Cargando…
The synergy factor: a statistic to measure interactions in complex diseases
BACKGROUND: One challenge in understanding complex diseases lies in revealing the interactions between susceptibility factors, such as genetic polymorphisms and environmental exposures. There is thus a need to examine such interactions explicitly. A corollary is the need for an accessible method of...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706251/ https://www.ncbi.nlm.nih.gov/pubmed/19527493 http://dx.doi.org/10.1186/1756-0500-2-105 |
_version_ | 1782169059798810624 |
---|---|
author | Cortina-Borja, Mario Smith, A David Combarros, Onofre Lehmann, Donald J |
author_facet | Cortina-Borja, Mario Smith, A David Combarros, Onofre Lehmann, Donald J |
author_sort | Cortina-Borja, Mario |
collection | PubMed |
description | BACKGROUND: One challenge in understanding complex diseases lies in revealing the interactions between susceptibility factors, such as genetic polymorphisms and environmental exposures. There is thus a need to examine such interactions explicitly. A corollary is the need for an accessible method of measuring both the size and the significance of interactions, which can be used by non-statisticians and with summarised, e.g. published data. The lack of such a readily available method has contributed to confusion in the field. FINDINGS: The synergy factor (SF) allows assessment of binary interactions in case-control studies. In this paper we describe its properties and its novel characteristics, e.g. in calculating the power to detect a synergistic effect and in its application to meta-analyses. We illustrate these functions with real examples in Alzheimer's disease, e.g. a meta-analysis of the potential interaction between a BACE1 polymorphism and APOE4: SF = 2.5, 95% confidence interval: 1.5–4.2; p = 0.0001. CONCLUSION: Synergy factors are easy to use and clear to interpret. Calculations may be performed through the Excel programmes provided within this article. Unlike logistic regression analysis, the method can be applied to datasets of any size, however small. It can be applied to primary or summarised data, e.g. published data. It can be used with any type of susceptibility factor, provided the data are dichotomised. Novel features include power estimation and meta-analysis. |
format | Text |
id | pubmed-2706251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27062512009-07-07 The synergy factor: a statistic to measure interactions in complex diseases Cortina-Borja, Mario Smith, A David Combarros, Onofre Lehmann, Donald J BMC Res Notes Short Report BACKGROUND: One challenge in understanding complex diseases lies in revealing the interactions between susceptibility factors, such as genetic polymorphisms and environmental exposures. There is thus a need to examine such interactions explicitly. A corollary is the need for an accessible method of measuring both the size and the significance of interactions, which can be used by non-statisticians and with summarised, e.g. published data. The lack of such a readily available method has contributed to confusion in the field. FINDINGS: The synergy factor (SF) allows assessment of binary interactions in case-control studies. In this paper we describe its properties and its novel characteristics, e.g. in calculating the power to detect a synergistic effect and in its application to meta-analyses. We illustrate these functions with real examples in Alzheimer's disease, e.g. a meta-analysis of the potential interaction between a BACE1 polymorphism and APOE4: SF = 2.5, 95% confidence interval: 1.5–4.2; p = 0.0001. CONCLUSION: Synergy factors are easy to use and clear to interpret. Calculations may be performed through the Excel programmes provided within this article. Unlike logistic regression analysis, the method can be applied to datasets of any size, however small. It can be applied to primary or summarised data, e.g. published data. It can be used with any type of susceptibility factor, provided the data are dichotomised. Novel features include power estimation and meta-analysis. BioMed Central 2009-06-15 /pmc/articles/PMC2706251/ /pubmed/19527493 http://dx.doi.org/10.1186/1756-0500-2-105 Text en Copyright © 2009 Combarros et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Cortina-Borja, Mario Smith, A David Combarros, Onofre Lehmann, Donald J The synergy factor: a statistic to measure interactions in complex diseases |
title | The synergy factor: a statistic to measure interactions in complex diseases |
title_full | The synergy factor: a statistic to measure interactions in complex diseases |
title_fullStr | The synergy factor: a statistic to measure interactions in complex diseases |
title_full_unstemmed | The synergy factor: a statistic to measure interactions in complex diseases |
title_short | The synergy factor: a statistic to measure interactions in complex diseases |
title_sort | synergy factor: a statistic to measure interactions in complex diseases |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706251/ https://www.ncbi.nlm.nih.gov/pubmed/19527493 http://dx.doi.org/10.1186/1756-0500-2-105 |
work_keys_str_mv | AT cortinaborjamario thesynergyfactorastatistictomeasureinteractionsincomplexdiseases AT smithadavid thesynergyfactorastatistictomeasureinteractionsincomplexdiseases AT combarrosonofre thesynergyfactorastatistictomeasureinteractionsincomplexdiseases AT lehmanndonaldj thesynergyfactorastatistictomeasureinteractionsincomplexdiseases AT cortinaborjamario synergyfactorastatistictomeasureinteractionsincomplexdiseases AT smithadavid synergyfactorastatistictomeasureinteractionsincomplexdiseases AT combarrosonofre synergyfactorastatistictomeasureinteractionsincomplexdiseases AT lehmanndonaldj synergyfactorastatistictomeasureinteractionsincomplexdiseases |